Should we be more cautious about replacement of vitamin B12 in patients with cancer receiving cytotoxic chemotherapy?

Autor: Eren, O.O., Ozturk, M.A., Sonmez, O.U., Oyan, B.
Přispěvatelé: Eren, O.O., Ozturk, M.A., Sonmez, O.U., Oyan, B., Yeditepe Üniversitesi
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Popis: Vitamin B12 (Cbl) deficiency may cause hematologic and neurologic dysfunction. Replacement therapy is effective in correcting hematologic abnormalities and improving neurologic symptoms. Cbl is known to have antioxidant activity. This antioxidant activity may antagonize the effects of chemotherapeutics (i.e. genotoxic effects of paclitaxel) on tumor DNA. We claim that Cbl replacement should be done more cautiously in patients receiving cytotoxic chemotherapy. © 2014 Elsevier Ltd.
Databáze: OpenAIRE